Biocon Biologics
Dhaval Bhatt is an experienced professional in the biotechnology field, currently serving as an Assistant Manager at Biocon Biologics since November 2022. Prior experience includes a role as Senior Executive MSAT at Intas Pharmaceuticals Ltd. in the Biopharma Division from June 2021 to October 2022, and a previous position as Senior Executive at Biocon Biologics, focusing on downstream manufacturing batch operations from February 2019 to June 2021. Earlier career roles consist of Senior Executive and Trainee Executive in microbial downstream processing at Intas Pharmaceuticals and a Technical Trainee position at Cadila Pharmaceuticals Limited in the R&D biotech department. Dhaval's foundational training began with a Project Trainee position at the National Chemical Laboratory, focusing on plant tissue culture techniques. Academic credentials include a Master's degree in Biotechnology from Vellore Institute of Technology and a Bachelor of Engineering in Biotechnology from V.V.P Engineering College.
This person is not in the org chart
This person is not in any teams
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics